| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |







Departments of *Medicine and
Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; and
Department of Medicine, Shanghai Changzheng Hospital, Shanghai, China
Correspondence to Dr. Gregory G. Germino, Johns Hopkins University School of Medicine, Departments of Medicine and Molecular Biology and Genetics, Division of Nephrology, Ross 958, 720 Rutland Avenue, Baltimore, MD 21205. Phone: 410-614-0089; Fax: 410-614-5129; E-mail: ggermino{at}jhmi.edu
Gene targeting has been used to create a variety of lines of mice with Pkd1 mutations that share many common features. Homozygous Pkd1 mutants invariably develop pancreatic and renal cysts if they survive to day 15.5 post coitum and die in either the fetal or the perinatal period. In contrast, mice with heterozygous mutations of Pkd1 are generally normal and have few if any renal cysts. These features have limited the utility of these models as tools to study the pathogenesis of cyst formation and the effect of various therapeutic interventions on disease progression. This report describes a new line of mice with a floxed allele of Pkd1 (Pkd1cond) that has an FRT-flanked neomycin cassette inserted into intron 1 and lox P sites inserted into intron 1 and intron 4. The Pkd1cond allele is fully functional, and homozygotes are viable and healthy. It is shown that the lox P and FRT sites can be selectively induced to recombine to produce two new alleles, Pkd1del24 and Pkd1cond-
neo, by crossing to animals that express either the cre or FLPe recombinase, respectively. It is found that Pkd1del24 allele functions as a true null, whereas presence or absence of the neomycin gene has no functional effects. It also is shown that somatic loss of Pkd1 results in renal and hepatic cysts. This new line of mice will be invaluable in the study of Pkd1 biology and serve as a powerful new tool that can be used to study the pathogenesis of autosomal dominant polycystic kidney disease.
Related Article
J. Am. Soc. Nephrol. 2004 15: 2955-2958.
This article has been cited by other articles:
![]() |
S. Shibazaki, Z. Yu, S. Nishio, X. Tian, R. B. Thomson, M. Mitobe, A. Louvi, H. Velazquez, S. Ishibe, L. G. Cantley, et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1 Hum. Mol. Genet., June 1, 2008; 17(11): 1505 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yu, K. Hackmann, J. Gao, X. He, K. Piontek, M. A. Garcia-Gonzalez, L. F. Menezes, H. Xu, G. G. Germino, J. Zuo, et al. Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure PNAS, November 20, 2007; 104(47): 18688 - 18693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Garcia-Gonzalez, L. F. Menezes, K. B. Piontek, J. Kaimori, D. L. Huso, T. Watnick, L. F. Onuchic, L. M. Guay-Woodford, and G. G. Germino Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway Hum. Mol. Genet., August 15, 2007; 16(16): 1940 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wei, K. Hackmann, H. Xu, G. Germino, and F. Qian Characterization of cis-Autoproteolysis of Polycystin-1, the Product of Human Polycystic Kidney Disease 1 Gene J. Biol. Chem., July 27, 2007; 282(30): 21729 - 21737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Ahrabi, S. Terryn, G. Valenti, N. Caron, C. Serradeil-Le Gal, D. Raufaste, S. Nielsen, S. Horie, J.-M. Verbavatz, and O. Devuyst PKD1 Haploinsufficiency Causes a Syndrome of Inappropriate Antidiuresis in Mice J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1740 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Harris, K. T. Bae, S. Rossetti, V. E. Torres, J. J. Grantham, A. B. Chapman, L. M. Guay-Woodford, B. F. King, L. H. Wetzel, D. A. Baumgarten, et al. Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3013 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shillingford, N. S. Murcia, C. H. Larson, S. H. Low, R. Hedgepeth, N. Brown, C. A. Flask, A. C. Novick, D. A. Goldfarb, A. Kramer-Zucker, et al. From the Cover: The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease PNAS, April 4, 2006; 103(14): 5466 - 5471. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Allen, K. B. Piontek, E. Garrett-Mayer, M. Garcia-Gonzalez, K. L. Gorelick, and G. G. Germino Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors Hum. Mol. Genet., January 1, 2006; 15(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. M. Wright, F. Qian, G. G. Germino, and W. B. Guggino Polycystin 2 Interacts with Type I Inositol 1,4,5-Trisphosphate Receptor to Modulate Intracellular Ca2+ Signaling J. Biol. Chem., December 16, 2005; 280(50): 41298 - 41306. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673